BIOMAT Database Logo BIOMAT Database Logo

Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers. 1979

M Danhof, and D D Breimer

UI MeSH Term Description Entries
D008297 Male Males
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Danhof, and D D Breimer
Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses.
May 1998, Biopharmaceutics & drug disposition,
M Danhof, and D D Breimer
Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.
January 1994, The Journal of antimicrobial chemotherapy,
M Danhof, and D D Breimer
A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
May 1996, Biopharmaceutics & drug disposition,
M Danhof, and D D Breimer
Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers.
November 2004, Biopharmaceutics & drug disposition,
M Danhof, and D D Breimer
Pharmacodynamics of 250 mg and 500 mg oral furosemide in peritoneal dialysis
.
December 2019, International journal of clinical pharmacology and therapeutics,
M Danhof, and D D Breimer
Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers.
January 1995, Infection,
M Danhof, and D D Breimer
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
January 2006, International journal of antimicrobial agents,
M Danhof, and D D Breimer
Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effects on antipyrine pharmacokinetics.
May 1992, Xenobiotica; the fate of foreign compounds in biological systems,
M Danhof, and D D Breimer
Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin.
December 1994, General pharmacology,
M Danhof, and D D Breimer
Interchangeability of two 500 mg amoxicillin capsules with one 1000 mg amoxicillin tablet after a single oral administration.
July 2010, Indian journal of pharmaceutical sciences,
Copied contents to your clipboard!